• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Healthcare·039840.KQ
Share

DIO Corporation Stocks

₩ 12400Last Updated 20.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

₩ 110.65M

₩ 12400
Key Takeaways

Risk factor

Considerable default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Based in South Korea, DIO Corporation is a key player in the manufacturing and distribution of dental implants. Its extensive range of implant systems includes UFII internal (both submerged and non-submerged), FTN external, and protem mini systems. The company further provides UV active components, activators, and essential instrument kits. In addition to dental implants, DIO offers dental digital solutions, a variety of dental products, and cardiovascular medical devices. Its global reach extends to approximately 70 countries through its export activities. The firm, which was founded in 1988, was initially known as DSI Co., Ltd before rebranding as DIO Corporation in August 2008. It is headquartered in Busan, South Korea.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of 039840.KQ is 23753 and suggests 88.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.07.2026 19:20

"KazMunayGas" Is Prepared to Pay the Kashagan Fine Despite Its Partners' Opposition — Bloomberg

20.07.2026 19:01

The Motley Fool called Wall Street's expectations for Oklo's stock growth "overblown"

20.07.2026 17:35

Yemeni Houthis have announced a blockade of Saudi Arabian shipping in the Red Sea

20.07.2026 16:56

Ryanair lost a third of its profits due to the war in the Middle East. Its stock plummeted 7%.

20.07.2026 16:55

Small-cap rival Nebius plummeted by a third despite its partnership with Nvidia

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026